Dyne Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,572 |
Gross Profit | -500 | -502 | 786 | |
EBITDA | -104,614 | -110,260 | -121,870 | -96,658 |
EBIT | -105,137 | -110,763 | -122,372 | -97,108 |
Net Income | -108,041 | -110,857 | -115,361 | -89,542 |
Net Change In Cash | 0 | 0 | 0 | 1,572 |
Free Cash Flow | -109,964 | -94,763 | -106,874 | -85,410 |
Cash | 573,610 | 485,040 | 472,255 | 435,449 |
Basic Shares | 141,810 | 113,873 | 109,912 | 101,982 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,243 | -2,461 | -3,345 | -1,088 |
EBITDA | -315,175 | -233,476 | -169,279 | -148,937 |
EBIT | -317,418 | -235,937 | -170,962 | -150,025 |
Net Income | -317,418 | -235,937 | -165,237 | -149,291 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -294,745 | -188,887 | -156,712 | -123,181 |
Cash | 435,449 | 121,626 | 172,147 | 200,825 |
Basic Shares | 94,144 | 59,683 | 51,976 | 50,895 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.76 |
2025-06-30 | -$0.97 |
2025-03-31 | -$1.05 |
